Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 0.770 | 0.770 | 0.000 |
Shares | 99.230 | 99.230 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 16.240 | 21.770 |
Price to Book | 3.393 | 3.989 |
Price to Sales | 1.112 | 2.260 |
Price to Cash Flow | 13.583 | 16.880 |
Dividend Yield | 2.067 | 1.345 |
5 Years Earnings Growth | 8.746 | 11.341 |
Number of long holdings: 35
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
GSK plc DRC | US37733W2044 | 5.75 | 41.54 | -1.02% | |
Eli Lilly | US5324571083 | 5.58 | 837.29 | +0.66% | |
Sanofi | FR0000120578 | 5.24 | 90.75 | -0.29% | |
HCA | US40412C1018 | 5.16 | 336.82 | -0.03% | |
McKesson | US58155Q1031 | 5.03 | 586.11 | +1.12% | |
Roche Holding Participation | CH0012032048 | 5.01 | 239.90 | +0.76% | |
Novo Nordisk B | DK0062498333 | 4.55 | 971.5 | -0.18% | |
Elevance Health | US0367521038 | 4.40 | 541.04 | +0.19% | |
Pfizer | US7170811035 | 4.09 | 28.80 | -2.54% | |
Novartis | CH0012005267 | 4.04 | 94.73 | -0.27% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Fondsfinans Norden | 2.77B | 18.01 | 8.67 | - | ||
Fondsfinans Norge | 2.35B | 13.02 | 14.51 | 12.24 | ||
Fondsfinans Aktiv 60/40 | 329.01M | 8.61 | 6.95 | 8.42 | ||
Fondsfinans Global Energi | 185.25M | 8.94 | -0.12 | -1.48 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review